PhytoCeuticals, Inc., strongly cautions its customers that some claims being made by IS Clinical about their products improperly uses scientific publications, clinical trials and research that are the exclusive property of PhytoCeuticals, Inc. and its founder, Dr. Mostafa Omar.
Dr. Mostafa Omar, PhytoCeutical’s president, is the highly respected developer and manufacturer of proprietary skin care formulations and the inventor of Stable Liquid L-Ascorbic Acid (Vitamin C).
PhytoCeuticals has developed several formulations, including stabilized liquid L-Ascorbic Acid in 1994. The company had distributed these products through Cellex-C, SkinCeuticals and IS Clinical. PhytoCeuticals permitted these companies the use of these scientific publications, clinical trials and research citations to support the marketing of PhytoCeuticals formulations.
PhytoCeuticals terminated its relationship (July 1, 2008) with IS Clinical by Innovation Skincare (Science of Skincare Inc.). Therefore IS Clinical no longer distributes any products using PhytoCeuticals formulations.
In addition, these companies surrendered the rights to use this materials for advertising and publicity claims. The only legal use of these studies is to support the sale of products formulated or developed by Dr. Omar and PhytoCeuticals, Inc.
PhytoCeuticals continues to retain the ownership of all its proprietary formulations, as well as the scientific research, publications, patents and grants from National Cancer Institute (NCI) and National Institute of Health (NIH).
Since the termination of the business relationship, PhytoCeuticals has received numerous requests from customers who have purchased IS Clinical products, (which do not contain PhytoCeuticals formulations) to exchange these IS Clinical products for genuine PhytoCeuticals PHYTO-C products.
Dr. Omar has stated that, “The acceptance of exchanges of IS Clinical new products for PhytoCeuticals PHYTO-C products was initially a courtesy to patients who thought they were still purchasing our formulations. It is my ethical duty to help and treat these patients – which is more important then making a profit. But we must be fair.”
Any purchaser of IS Clinical skincare products who is dissatisfied, should return these products to IS Clinical directly for refunds or substitute products. PhytoCeuticals has no responsibility and does not guarantee IS Clinical products.
PhytoCeuticals is currently is unaware of any controlled clinical testing, stability testing or research undertaken by IS Clinical with respect to the products it has been selling since July 1, 2008.
Dr. Mostafa Omar stated, “Normally a clinical study and testing of a new formulation takes at least 5 years or more before a product is launched into the marketplace. To the extent that IS Clinical claims that it has undertaken extensive research in connection with its products, customers should confirm that the research cited is genuine and not proprietary research using authentic PhytoCeuticals formulations.”
PhytoCeuticals, Inc. is the market leader in antioxidant skin care products. Established by Dr. Mostafa Omar and based in the United States, the company was awarded NCI grant #1 R43- CA83538-01A1 for “Prevention of UV Photoinjury in Skin by Antioxidants”, NCI Grant #1-R43-CA94484-01 for “Photoprotection of Skin by Topical Selenium” , Olive patent # 6,743,499 B2 and Aleoferon patent # 4861761 & NIH.
For further information, please visit www.phyto-ceutical.com or contact us directly at 201-791-2255 or firstname.lastname@example.org.
Via EPR Network
More Healthcare press releases